Clinical Trial Update: Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medication Treated With Two iStents [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating two topical hypotensive medications with two iStents in subjects with primary open-angle glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• iStent
• topical hypotensive medications

Snippet

Sponsor: Glaukos Corporation | Conditions: Subjects With Primary Open-angle Glaucoma (POAG) | Phase 4 | Status: COMPLETED